Cabaletta Bio Inc [NASDAQ: CABA] slipped around -0.39 points on Thursday, while shares priced at $1.87 at the close of the session, down -17.26%.
Compared to the average trading volume of 1.04M shares, CABA reached a trading volume of 6617987 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
What do top market gurus say about Cabaletta Bio Inc [CABA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CABA shares is $22.10 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CABA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Cabaletta Bio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 10, 2024. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on February 05, 2024, representing the official price target for Cabaletta Bio Inc stock. Previously, the target price had yet another raise to $38, while William Blair analysts kept a Outperform rating on CABA stock.
The Average True Range (ATR) for Cabaletta Bio Inc is set at 0.41 The Price to Book ratio for the last quarter was 0.52, with the Price to Cash per share for the same quarter was set at 3.74.
How has CABA stock performed recently?
Cabaletta Bio Inc [CABA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -50.53. With this latest performance, CABA shares dropped by -53.60% in over the last four-week period, additionally sinking by -83.32% over the last 6 months – not to mention a drop of -89.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CABA stock in for the last two-week period is set at 22.57, with the RSI for the last a single of trading hit 15.07, and the three-weeks RSI is set at 27.77 for Cabaletta Bio Inc [CABA]. The present Moving Average for the last 50 days of trading for this stock 4.07, while it was recorded at 2.48 for the last single week of trading, and 10.19 for the last 200 days.
Cabaletta Bio Inc [CABA]: Deeper insight into the fundamentals
Cabaletta Bio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 8.11 and a Current Ratio set at 8.11.
Earnings analysis for Cabaletta Bio Inc [CABA]
With the latest financial reports released by the company, Cabaletta Bio Inc posted -0.46/share EPS, while the average EPS was predicted by analysts to be reported at -0.39/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.07. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CABA.
Insider trade positions for Cabaletta Bio Inc [CABA]
There are presently around $100.47%, or 103.68%% of CABA stock, in the hands of institutional investors. The top three institutional holders of CABA stocks are: JENNISON ASSOCIATES LLC with ownership of 5.55 million shares, which is approximately 11.2498%. BLACKROCK INC., holding 4.76 million shares of the stock with an approximate value of $$35.58 million in CABA stocks shares; and BLACKROCK INC., currently with $$29.01 million in CABA stock with ownership which is approximately 7.8661%.
